Results 91 to 100 of about 1,073 (146)

Selective extraocular muscle regression following tocilizumab in active thyroid associated ophthalmopathy: a 3D MRI-based retrospective study. [PDF]

Front Endocrinol (Lausanne)
Nan F, Zhang Y, Ma Y, Yang C, Ma X, An N, Piao S, Zhang X, Yang L, Zheng Y, Cui X, Ma T, Mai Q, Zhuang W, Li Q.   +14 more
europepmc   +1 more source

Orbital MRI for thyroid eye disease activity staging: a systematic review and meta-analysis. [PDF]

BMC Ophthalmol
Liu S, Sun C, Liu S, Zhu T, Kikkawa DO, Lu W.   +5 more
europepmc   +1 more source

Orbital Radiotherapy for Thyroid-Associated Orbitopathy in the Era of Targeted Biologics: Reposition, Not Replace. [PDF]

Medicina (Kaunas)
Jo JH, Seol KH.
europepmc   +1 more source

Interpretable machine learning for severity classification of thyroid eye disease using orbital anatomical features. [PDF]

Front Med (Lausanne)
Shi R, Gao L, Jiao S, Wang L, Li J, Wang B.   +5 more
europepmc   +1 more source

A Nationwide Survey by the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS) on the Management of Thyroid Eye Disease in South Korea. [PDF]

Korean J Ophthalmol
Surl D, Ko J, Yang J, Yoon JS.
europepmc   +1 more source

The burden of thyroid eye disease: Evaluating treatment outcomes on quality of life. [PDF]

Eur J Ophthalmol
Lai AC, Yu BE, Malvankar-Mehta M.
europepmc   +1 more source

Medium-dose intravenous methylprednisolone pulse therapy for thyroid-associated orbitopathy. [PDF]

Int J Ophthalmol
Khan AR, Sultana S, Rashid R, Afzal F, Kadir SMU.   +4 more
europepmc   +1 more source

Machine Learning-Based Cytokine Endotyping of Thyroid Eye Disease. [PDF]

Invest Ophthalmol Vis Sci
Jing G, Wu X, Huang Z, Tang J, Ao Y, Yang X, Ma R, Tang X, Wu W, Fu S.   +9 more
europepmc   +1 more source

Diagnostic Approaches to and Disaese Course Modifying Therapies in Graves Orbitopathy

Graves' Orbitopathy (GO) is an autoimmune condition that primarily affects the orbit, causing inflammation, muscle expansion, and tissue changes. Although often linked to Graves' Disease (GD), 5-10% of GO patients may not have GD at diagnosis.
Muthomi, Brenda Shey Wanjira
core  

Identification and Validation of Biomarkers in the Development and Progression of Graves' Ophthalmopathy. [PDF]

Invest Ophthalmol Vis Sci
Song C, Xing C, Cheng J, Wang X, Huang A, Ma Q, Chen H, Duan Y, Hai Y, Liu L, Zhu Y, Shen J.   +11 more
europepmc   +1 more source